Skip to content

Clinical trials

Phase 1/2 Retinal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Diseases Phase: Phase 1/2 Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20092
20101
20114
20171
20181
20197
20201
20211
20233
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated6
Active, not recruiting4
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)3
AsclepiX Therapeutics, Inc.2
ProQR Therapeutics2
SparingVision2
University of Sao Paulo2
Astellas Institute for Regenerative Medicine1
David M. Brown, M.D.1
Editas Medicine, Inc.1
Elisigen, Inc.1
Eyestem Research Pvt. Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Diseases26
Eye Diseases16
Retinal Degeneration13
Macular Degeneration10
Eye Diseases, Hereditary6
Retinitis Pigmentosa6
Vision Disorders6
Retinal Dystrophies5
Central Serous Chorioretinopathy3
Diabetic Retinopathy3

Trials

Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.